Clinical Trial Detail

NCT ID NCT03997448
Title Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Nataliya Uboha
Indications

gastric adenocarcinoma

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

Therapies

Abemaciclib + Pembrolizumab

Age Groups: adult senior

No variant requirements are available.